Efficacy and Safety of an Attenuated-Dose Sunitinib Regimen in Metastatic Renal Cell Carcinoma: Results From a Prospective Registry in Singapore-Reference-Cited by-同舟云学术

Efficacy and Safety of an Attenuated-Dose Sunitinib Regimen in Metastatic Renal Cell Carcinoma: Results From a Prospective Registry in Singapore

Published:2015-08 Issue:4 Volume:13 Page:e285-e295
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Tan Hui Shan,Li Huihua,Hong Yu Wen,Toh Chee-Keong,Wong Alvin,Lopes Gilberto,Tay Miah Hiang,Chan Alexandre,Yao Xin,Tang Tiffany,Ng Quan Sing,Kanesvaran Ravindran,Chau Noan Minh,Tan Min-Han

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. Sunitinib, sorafenib, temsirolimus or bevacizumab in the treatment of metastatic renal cell carcinoma: a review of health economic evaluations;Norum;J Chemother,2010

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

3. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

4. Pazopanib versus sunitinib in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2013

5. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review;Urologia Internationalis;2024

2. Real-World Evidence Studies in Oncology Therapeutics: Hope or Hype?;Indian Journal of Surgical Oncology;2023-06-21

3. Use of real-world evidence for oncology clinical decision making in emerging economies;Future Oncology;2021-08

4. Efficacy and Prognostic Factors of Sunitinib as First-Line Therapy for Patients With Metastatic Renal Cell Carcinoma in an Arab Population;JCO Global Oncology;2020-11

5. The role of sunitinib in the therapy of metastatic renal cell carcinoma;Meditsinskiy sovet = Medical Council;2020-07-30